Nureca Limited (NSE:NURECA)
272.98
+27.41 (11.16%)
Jul 14, 2026, 3:30 PM IST
Nureca Market Cap
Nureca has a market cap or net worth of 2.62 billion as of July 14, 2026. Its market cap has decreased by -0.54% in one year.
Market Cap
2.62B
Enterprise Value
2.22B
Revenue
1.47B
Ranking
n/a
PE Ratio
130.49
Stock Price
272.98
Market Cap Chart
Since February 25, 2021, Nureca's market cap has decreased from 6.46B to 2.62B, a decrease of -59.36%. That is a compound annual growth rate of -15.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 2.62B | -14.77% |
| Dec 31, 2025 | 3.08B | 8.84% |
| Dec 31, 2024 | 2.83B | -33.87% |
| Dec 29, 2023 | 4.28B | -14.10% |
| Dec 30, 2022 | 4.98B | -75.15% |
| Dec 31, 2021 | 20.05B | 210.49% |
| Feb 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.64T |
| Divi's Laboratories | 1.81T |
| Apollo Hospitals Enterprise | 1.27T |
| Cipla | 1.16T |
| Yash Optics & Lens | 3.00B |
| Lyka Labs | 2.54B |
| Lotus Eye Hospital and Institute | 2.46B |
| Nectar Lifesciences | 2.17B |